Candida glabrata Pneumonia in a Patient with Chronic Obstructive Pulmonary Disease

  title={Candida glabrata Pneumonia in a Patient with Chronic Obstructive Pulmonary Disease},
  author={Onur Yazıcı and Mustafa Cortuk and Hasan Casim and Erdoğan Çetinkaya and Ali Mert and Ali Ramazan Benli},
  journal={Case Reports in Infectious Diseases},
Pneumonia remains an important cause of morbidity and mortality among infectious diseases. Streptococcus pneumoniae and viruses are the most common cause of pneumonia. Candidiasis in such patients has been associated with haemodialysis, fungal colonization, exposure to broad-spectrum antibiotics, intensive care unit (ICU) hospitalization, and immunocompromised patients. The most common cause of infection is C. albicans. The case presented here is of a 66-year-old male patient diagnosed with C… Expand
Antifungal Effects of PC945, a Novel Inhaled Triazole, on Candida albicans Pulmonary Infection in Immunocompromised Mice
Although antifungal therapy is standard treatment for Candida infections observed in other organs such as the vagina and skin, no practical guidelines to treat Candida infection in the respiratory tract, except for invasive candidiasis, have been developed. Expand
Antifungal effects of PC945, a novel inhaled triazole, on Candida albicans-infected immunocompromised mice
Antifungal susceptibility testing on 88 candida isolates revealed that PC945 has potent effects on Candida species broadly, and has the potential to be a novel topical therapy for the treatment of C. albicans pulmonary infection in humans. Expand
Fungal Infections and ABPA
Emerging immunotherapeutic approaches targeting Th2-mediated hyperresponsiveness, multi-omics technologies and fungal sequencing platforms represent promising areas for future work that require strong and sustained investment to improve the understanding of the complex host-microbe-immunological interaction that underpins CF-associated fungal diseases. Expand


A probable case of aspiration pneumonia caused by Candida glabrata in a non-neutropenic patient with candidemia.
A 71-year-old woman treated for heart failure and developed aspiration pneumonia, which was refractory to antibacterial treatment, received antifungal treatment against C. glabrata, which resulted in resolution of pneumonia and candidemia. Expand
Candida Glabrata and Candida Tropicalis in an Immunocompetent Patient
It is understood that pneumonia is rarely caused by Candida species in patients who are admitted to the hospital, however, health care professionals should be aware that Candida pneumonia should be suspected as part of the differential diagnosis even in immunocompetent patients, particularly if they have recently traveled outside the United States. Expand
Pneumonia caused by Candida krusei and Candida glabrata in a patient with chronic myeloid leukemia receiving imatinib mesylate treatment.
It is indicated that in some patients, as previously observed, the long-term administration of targeted therapy might affect immunity and predispose patients to opportunistic and life-threatening fungal infections. Expand
Candida glabrata perinephric abscess.
A case of Candida glabrata perinephric abscess is reported in a patient with diabetes mellitus who had a recent episode of pyelonephritis that was treated with antibiotics. Expand
Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia.
Candida colonization of the respiratory tract is common in patients receiving MV for > 2 days and is associated with prolonged ICU and hospital stays, and with an increased risk of Pseudomonas VAP. Expand
[Candida glabrata pneumonia in a non-immunosuppressed patient: diagnostic imaging with digital luminescence radiography and CT].
An atypical case of Candida glabrata pneumonia in a non-immunocompromised patient is reported and the imaging findings on digital radiography and computed tomography are described. Expand
Pulmonary fungal infection: emphasis on microbiological spectra, patient outcome, and prognostic factors.
Pulmonary fungal infection of community-acquired origins is becoming a serious problem, and early diagnosis with prompt antifungal therapy, or even with surgical intervention, might be warranted to save patients' lives. Expand
[Retrospective analysis of invasive fungal infection in surgical intensive care unit].
The morbidity of IFI in the authors' SICU was comparatively low, and the same of the incidence of fungemia, but the mortality of I FI patients was markedly high. Expand
Mortality rates and risk factors associated with nosocomial Candida infection in a respiratory intensive care unit.
The presence of catheters and related infections, IMV, multiple antibiotics use, parenteral nutrition, VAT, sepsis and VAP were founded as major risk factors for patients with NCI. Expand
Guidelines for treatment of candidiasis.
  • P. Pappas, J. Rex, +4 authors J. Edwards
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2004
This work presents a novel and scalable approach that allows for real-time decision-making about whether or not to vaccinate children against infection by a single infectious agent. Expand